Support for eligible patients prescribed Hagemia and the people beside them.
recombinant factor XII therapy
Designed for patients with Factor XII Deficiency and built around the “Spark” of the intrinsic coagulation pathway.
Eligibility depends on program requirements and insurance status.
Patients may designate a loved one or authorized representative.
Patients can track enrollment, refills, shipments, and re-enrollment reminders through the portal.